Dopamine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dopamine Hydrochloride Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on Nov 6, 2017.
Shortage details
- Status
- Current
- Company
- Baxter Healthcare
- Package NDC
- 0338-1007-02
- Dosage Form
- Injection
- Presentation
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)
- Initial Posting
- Nov 6, 2017